Iran is grappling with a deadly flu outbreak as H3N2 influenza spreads rapidly across major cities. Consequently, this deadly flu outbreak has claimed over 100 lives, leaving many families unable to access vaccines. High costs and limited supply have therefore forced residents to make difficult choices to protect their loved ones. Health officials report that at least 101 people have died from pneumonia linked to H3N2. Moreover, they warn that the outbreak has peaked while winter conditions continue to worsen. The crisis highlights gaps in government policy and healthcare preparedness, with vulnerable populations facing the greatest risk.
Many families have struggled to secure vaccines. For instance, Shadi, a mother in Tehran, spent nearly all her savings to vaccinate her children, leaving herself and her husband unprotected. Similarly, Hanieh in Ahvaz found that her parents, both high-risk patients, could no longer receive free doses from government pharmacies. Authorities recently removed free vaccine allocations for sensitive groups, thereby creating a system where access depends on the ability to pay. Meanwhile, pharmacies in several cities reported limited supplies, sometimes only a few doses per branch, leaving many without protection.
Experts warn that even vaccination does not guarantee immunity. Rouzbeh Esfandiari, a former Tehran emergency room doctor, noted that vaccines are based on previous strains and may be less effective against the current H3N2 virus. Nevertheless, he stressed that vaccination remains the primary preventive measure against this deadly flu outbreak. The domestic Iranian vaccine, Fluguard, remains controversial. Authorities caution that it is not approved for children under 18 and is still under study. In addition, some individuals report limited effectiveness, raising concerns about quality and trust.
Air pollution compounds the problem. Tehran and other cities experience heavy smog in winter, weakening residents’ respiratory systems. Consequently, polluted air increases susceptibility to flu and secondary infections like bacterial pneumonia or COVID-19. Officials emphasize that most fatalities involved unvaccinated individuals. However, vaccine scarcity and rising costs leave millions exposed.
Therefore, medical experts urge immediate public health measures to expand vaccine access and reduce exposure to high-risk environments. As Iran confronts this deadly flu outbreak, authorities face mounting pressure to stabilize supply chains and protect vulnerable populations. Public health campaigns and stricter pollution controls could mitigate some risks. Nevertheless, the coming months remain critical.